Vaxcyte
PCVX
PCVX
187 hedge funds and large institutions have $3.15B invested in Vaxcyte in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 70 increasing their positions, 63 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
19% less capital invested
Capital invested by funds: $3.9B → $3.15B (-$745M)
29% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 31
Holders
187
Holding in Top 10
9
Calls
$6.92M
Puts
$3.47M
Top Buyers
| 1 | +$72.1M | |
| 2 | +$61.4M | |
| 3 | +$53.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$43.2M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$26.6M |
Top Sellers
| 1 | -$41.4M | |
| 2 | -$23.3M | |
| 3 | -$20.8M | |
| 4 |
DM
Deerfield Management
New York
|
-$15.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$13.5M |